1 min read
Signify Health to Present at the Barclays Global Healthcare Conference
DALLAS and NEW YORK – Signify Health, Inc. (NYSE: SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, today announced a presentation at the following investor conference:
Barclays Global Healthcare Conference 2021
2 min read
Signify Health Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
DALLAS & NORWALK, Conn.—Signify Health, Inc. (NYSE: SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the closing of its initial public offering of 27,025,000 shares of its Class A common stock at a price to the public of $24.00 per share. The number of shares offered and sold by Signify Health included the exercise in full of the underwriters’ option to purchase up to an additional 3,525,000 shares of Class A common stock from Signify Health.
2 min read
Signify Health Announces Pricing of Initial Public Offering
DALLAS & NORWALK, Conn.—Signify Health, Inc. a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, today announced the pricing of its initial public offering of 23,500,000 shares of its Class A common stock at a price to the public of $24.00 per share. In addition, the underwriters have a 30-day option to purchase up to an additional 3,525,000 shares of Class A common stock from Signify Health at the initial public offering price less underwriting discounts and commissions.
Topics: Expansion
2 min read
Signify Health Files Registration Statement for Proposed Initial Public Offering
DALLAS and NORWALK, Conn. – January 19, 2021 – Signify Health, Inc. a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined.
4 min read
Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials
BOSTON, DURHAM, N.C. and DALLAS – Jan. 13, 2021 – Parexel and Signify Health today announced a strategic collaboration to provide customers with new solutions to enable access to a more diverse and traditionally underrepresented population for their clinical trials. The partnership will focus on improving patient access to clinical trials, bringing studies to patients in their own homes, and identifying relevant social determinants of health (SDoH) to facilitate connections among local resources, patients, and caregivers.
